Benzinga | May 4, 2021 04:38PM EDT

Theravance Biopharma Q1 EPS $(1.24) Misses $(1.05) Estimate, Sales $14.30M Miss $17.27M Estimate

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(1.24) per share which missed the analyst consensus estimate of $(1.05) by 18.1 percent. This is a 8.77 percent decrease over losses of $(1.14) per share from the same period last year. The company reported quarterly sales of $14.30 million which missed the analyst consensus estimate of $17.27 million by 17.20 percent. This is a 28.00 percent decrease over sales of $19.86 million the same period last year.